Ligand Pharmaceuticals | Zysk Na Akcję



Fiscal Kalendarz Obecny Prognoza Poprzedni Data
FY2024Q4 Dec/2024 1.27 1.18 1.05 Feb/27 2025
FY2024Q3 Sep/2024 1.84 1.34 1.02 Nov/07 2024
FY2024Q2 Jun/2024 1.40 1.40 1.42 Aug/06 2024
FY2024Q1 Mar/2024 1.20 0.84 2.28 May/07 2024
FY2023Q4 Dec/2023 1.05 0.66 1.36 Feb/27 2024
FY2023Q3 Sep/2023 1.02 0.62 1.31 Nov/08 2023
FY2023Q2 Jun/2023 1.42 0.64 1.03 Aug/08 2023
FY2023Q1 Mar/2023 2.28 0.95 0.58 May/04 2023
FY2022Q4 Dec/2022 1.36 1.18 1.8 Feb/22 2023
FY2022Q3 Sep/2022 1.31 0.44 1.58 Nov/07 2022
FY2022Q2 Jun/2022 1.03 0.46 1.63 Aug/08 2022
FY2022Q1 Mar/2022 0.58 0.66 1.41 May/04 2022

Eps Zmiana Data
Amgen USD 5.31 0.27 2024-12
Arrowhead Research USD -1.39 0.02 2024-12
Baxter International USD 0.58 0.22 2024-12
Bristol-Myers Squibb USD 1.67 0.13 2024-12
Eli Lilly USD 5.32 4.14 2024-12
Gilead Sciences USD 1.9 0.12 2024-12
GlaxoSmithKline GBP 0.23 0.27 2024-12
Glaxosmithkline USD 0.59 0.7 2024-12
Insmed USD -1.32 0.04 2024-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Ligand Pharmaceuticals USD 1.27 0.57 2024-12
MacroGenics USD 0.9 1.79 2024-09
Merck USD 1.72 0.15 2024-12
Pacira USD 0.91 0.12 2024-12
Pfizer USD 0.63 0.43 2024-12
Veracyte USD 0.36 0.17 2024-12



Ligand Pharmaceuticals Zysk Na Akcję - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.